Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 334 is a non-coding genomic sequence similar to the gene for 5S ribosomal RNA (5S rRNA) but is classified as a **pseudogene**, meaning it no longer produces functional RNA due to mutations, deletions, or lack of regulatory elements[4]. Functional 5S rRNA is a key component of the large ribosomal subunit, involved in the structural integrity and function of ribosomes during protein synthesis[1][3]. In contrast, the RNA5SP334 pseudogene is a nonfunctional DNA remnant and does not encode a functional RNA or protein product[4]. While the expression patterns of some pseudogenes have been linked to disease states and are topics of research in cancer biology, there is no evidence that RNA5SP334 itself serves as a direct disease biomarker, therapeutic target, or has clinical relevance at this time[6]. **Key Considerations:** - **Not a classical therapeutic target:** It is not a receptor, enzyme, or other functional macromolecule involved in signal transduction, metabolism, or cell communication. - **Not a functional gene product:** Pseudogenes generally lack protein-coding potential or regulatory capacity; most have no direct biological activity. - **Potential research interest:** Some pseudogenes modulate gene expression or have roles as non-coding RNAs in disease, but evidence for RNA5SP334 is lacking. **Correction note:** This entry is *not an active therapeutic target* and may be listed in error if the intention was to identify drug targets or functional biomolecules. It is a **non-coding pseudogene**, not a ribosomal protein or classic rRNA[4][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 334 (RNA5SP334).